1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

interleukin 6 ; Mus musculus







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34850494 Daidzein exerts neuroprotective activity against MPTP-induced Parkinson's disease in experimental mice and lipopolysaccharide-induced  BV2 microglial cells. 2022 Feb 1
2 35366203 Protective Effect of CP690550 in MPTP-Induced Parkinson's Like Behavioural, Biochemical and Histological Alterations in Mice. 2022 Apr 1
3 33784949 PGC-1α-siRNA suppresses inflammation in substantia nigra of PD mice by inhibiting microglia. 2021 Jun 1 1
4 31732967 MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1. 2020 Mar 1
5 32305864 Validation of an in vivo electrochemical immunosensing platform for simultaneous detection of multiple cytokines in Parkinson's disease mice model. 2020 Aug 1
6 32376269 Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model. 2020 Jul 15 1
7 31251998 Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice. 2019 Sep 1 1
8 29363729 (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease. 2018 Apr 1
9 26852411 Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease. 2017 Mar 1
10 28182002 Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease. 2017 Feb 9 2
11 25637482 Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease. 2015 May 1
12 24995576 CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson's disease mice. 2014 Sep 5 1
13 22772723 IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. 2012 Dec 2
14 20938211 MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain. 2011 1
15 21970803 Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice. 2011 Nov 30 1
16 20333481 Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. 2010 Oct 1
17 20925384 Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice. 2010 Nov 10 1
18 17574387 Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice. 2007 Jul-Aug 3
19 18196934 Influence of age and gender on cytokine expression in a murine model of Parkinson's disease. 2007 1
20 15589033 Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. 2005 Jan 1
21 15804595 Differential inflammatory activation of IL-6 (-/-) astrocytes. 2005 Apr 21 2
22 15862160 [Kinetic changes of plasma IL-1 and IL-6 levels in MPTP-induced Parkinson's disease model mice and their relationship with brain asymmetry]. 2005 May 3
23 15910760 In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization. 2005 May 31 2
24 16219171 The levels of plasma IL-1beta, IL-6 of C57BL/6J mice treated with MPTP and brain lateralization. 2004 Jun 3
25 12957371 Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice. 2003 Sep 19 2
26 12358740 Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. 2002 Oct 2
27 10499156 Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice. 1999 Sep 3